Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vertex Pharmaceuticals Incorporated VRTX

Healthcare  —  Biotechnology
526.19 3.81 0.73% as of 25 Sep
Market cap
$132.3B
P/E
30.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vertex Pharmaceuticals Incorporated (VRTX) Return on invested capital

Vertex Pharmaceuticals Incorporated's return on invested capital over the twelve months to 30 June 2026 was 24.1%, up 2.5 percentage points from fiscal 2025 (21.6%). Over the past ten years it has ranged from −37.3% (fiscal 2015) to 73.7% (fiscal 2022); the current reading is higher than 55% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2025 21.6% 23.03
FY2024 −1.40% (36.94)
FY2023 35.5% (38.14)
FY2022 73.7% 18.74
FY2021 54.9% (13.20)
FY2020 68.1% 42.02
FY2019 26.1% 4.76
FY2018 21.4% 7.62
FY2017 13.7% 12.82
FY2016 0.92% 38.19

Against its own ten years

Low −37.3% High 73.7%
Ten-year median 21.6%
Current reading's percentile 55

Return on invested capital against peers

Company Return on invested capital
ONC BeOne Medicines Ltd. - Sponsored ADR compare 60.2%
VRTX Vertex Pharmaceuticals Incorporated 24.1%
ARGX argenex SE compare 20.7%
REGN Regeneron Pharmaceuticals, Inc. compare 9.34%
RPRX Royalty Pharma PLC compare 5.28%
ALNY Alnylam Pharmaceuticals, Inc. compare 0.00%
RVMD Revolution Medicines, Inc. compare 0.00%
MRNA Moderna, Inc. compare −93.5%
INSM Insmed, Inc. compare −329.2%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on VRTX